Cargando…
The effect and safety of low-dose Tripterygium wilfordii in patients with type 2 diabetic nephropathy: A meta-analysis
This review aims to assess the efficacy and safety of low-dose Tripterygium wilfordii Hook F (TWHF) in treating type 2 diabetic nephropathy (DN) and provide high-level evidence supporting its normalized application. METHODS: Seven electronic databases were queried to locate trials that qualify. Rand...
Autores principales: | Chen, Yixuan, Lu, Meiqi, Feng, Yiting, Gao, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803423/ https://www.ncbi.nlm.nih.gov/pubmed/36596065 http://dx.doi.org/10.1097/MD.0000000000032504 |
Ejemplares similares
-
Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022) -
Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation
por: Gao, Ying, et al.
Publicado: (2021) -
Review of molecular biological research on the treatment of membranous nephropathy with Tripterygium glycosides based on TCM theory
por: Xu, Pengyu, et al.
Publicado: (2023) -
Exploring the pharmacological mechanisms of Tripterygium wilfordii against diabetic kidney disease using network pharmacology and molecular docking
por: Lu, Meiqi, et al.
Publicado: (2023) -
Effect of Cordyceps sinensis and Tripterygium wilfordii polyglycosidium on podocytes in rats with diabetic nephropathy
por: HAO, LI, et al.
Publicado: (2014)